Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TroVax in relapsed asymptomatic ovarian cancer
NCT01556841Phase 2Completed
- Sponsor
- University College London
- Start
- Nov 2013
- Primary completion
- Apr 2019
- Modality
- Oncolytic Viruses, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of MVA-5T4 in ovarian cancer, fallopian tube cancer (PFTC), primary peritoneal cancer (PPC), sponsored by University College London. Started Nov 2013; status: completed.
02
Drugs
MVA-5T4
03
Conditions
ovarian cancerfallopian tube cancer (PFTC)primary peritoneal cancer (PPC)
Beyond the preview
Go deeper on NCT01556841.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01556841.